Creative Drama in Physiotherapy and Rehabilitation Education

June 15, 2022 updated by: Nuray Alaca, Acibadem University

The Perceived Effect of Communication Skills Education Integrated With Creative Drama on Physiotherapy and Rehabilitation Students' Empathy and Communication Skills to Develop With the Patient: A Randomized Controlled Study

Candidates who will provide the health services of the future should be ready to provide the safe and best health care services. In order to achieve this, it is recommended to use new training programs and methods that will provide similar situations to the working environment in the training of health workers. There are very few studies on the empathy and communication perceptions that creative drama education will create with the patient on physiotherapy and rehabilitation department students. Therefore, this study, the investigators aimed to investigate the perceived effect of communication skills training integrated with creative drama on physiotherapy and rehabilitation students' empathy and communication skills that will develop with the patient.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İstanbul, Turkey, +90
        • Acıbadem University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being willing to take FZT 233 Effective Communication with Creative Drama in Health course in any of the fall or spring semesters.

Exclusion Criteria:

  • Desire to take FZT 233 Effective Communication with Creative Drama in Health course at his own request.

    • Not wanting to participate in the study
    • Having a diagnosed psychological disorder and/or receiving psychological treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Active Comparator: Creative Drama Group
Effective Communication with Creative Drama in Health Course will be given to students for 2 hours a week for 14 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
interpersonal communication questionnaire
Time Frame: Change from Baseline interpersonal communication questionnaire at 14 weeks
It is stated that the first four items are related to communication anxiety and the last four items are related to communication trust. Each item has a 5-point Likert scale between 1 = strongly disagree 5 = strongly agree. High values indicate poor communication
Change from Baseline interpersonal communication questionnaire at 14 weeks
Jefferson Doctor Empathy Scale
Time Frame: Change from Baseline Jefferson Doctor Empathy Scale at 14 weeks
The score range is 20-140, with higher average scores representing higher levels of empathy.
Change from Baseline Jefferson Doctor Empathy Scale at 14 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale-communication
Time Frame: Change from Baseline Visual analog scale at 14 weeks
A visual analog scale between 0 and 10 will be used to evaluate the communication that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient. Zero will be set to none, 10 will be set to the maximum I can think of.
Change from Baseline Visual analog scale at 14 weeks
Visual analog scale-anxiety/stress
Time Frame: Change from Baseline Visual analog scale at 14 weeks
A visual analog scale between 0 and 10 will be used to evaluate the anxiety/stress that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient. Zero will be set to none, 10 will be set to the maximum I can think of.
Change from Baseline Visual analog scale at 14 weeks
Visual analog scale-motivation
Time Frame: Change from Baseline Visual analog scale at 14 weeks
A visual analog scale between 0 and 10 will be used to evaluate the motivation that may occur when students go into clinical practice at the beginning and end of the term and when they meet the patient. Zero will be set to none, 10 will be set to the maximum I can think of.
Change from Baseline Visual analog scale at 14 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2021

Primary Completion (Actual)

January 15, 2022

Study Completion (Actual)

February 15, 2022

Study Registration Dates

First Submitted

December 28, 2021

First Submitted That Met QC Criteria

January 12, 2022

First Posted (Actual)

January 26, 2022

Study Record Updates

Last Update Posted (Actual)

June 16, 2022

Last Update Submitted That Met QC Criteria

June 15, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ATADEK-2021/22/06

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Educational Problems

Clinical Trials on Creative Drama Education

3
Subscribe